American Chemical Society (ACS)

The discovery of green fluorescent protein (GFP), which is made by a jellyfish, transformed cell biology. It allowed scientists to stitch the GFP sequence to proteins from other organisms to trace their movements and interactions in living cells. Now, researchers reporting in ACS Applied Materials & Interfaces have designed peptide nanoparticles that can each glow in a variety of colors, opening the door for many new biomedical applications.
Scientists have tried to mimic the fluorescence of GFP in small molecules such as chromophore-containing polymers or fluorescent peptide nanostructures. Peptides, which are small pieces of proteins, are attractive because of their structural simplicity and biocompatibility. However, previous fluorescent peptide nanomaterials glow in only one color, which limits their use. Yuefei Wang and colleagues wanted to make peptides that can fluoresce in a rainbow of colors.
The researchers designed 12 peptides that contained 1-3 copies of the amino acids phenylalanine, tyrosine, tryptophan or histidine, all of which are weakly fluorescent in the visible range. They added a hydrophobic ferrocene group to one end of the peptide, which caused multiple peptides to assemble into spherical fluorescent nanoparticles. The ferrocene group also changed the emission properties, or colors, of the peptides. The researchers found that each peptide nanoparticle could glow in more than one color, and together, the 12-peptide palette encompassed all colors in the visible region of light. The peptide colors were photostable and showed no toxicity when added to human cells. These results indicate that the peptide nanoprobes could be substituted for fluorescent proteins, such as GFP, in biomedical imaging, although the fluorescence quantum yield is not as high, the researchers say.
Bioinspired fluorescent peptidyl nanoparticles with rainbow colors
Jia Kong, Jiaxing Zhang, Yuefei Wang, Wei Qi, Meimei Huang, Rongxin Su, Zhimin He
ACS Applied Materials & Interfaces (2020)
Contact information:
Yuefei Wang
School of Chemical Engineering and Technology, Tianjin University
wangyuefei@tju.edu.cn

Mecwins has described its AVAC technology, which labels target proteins with plasmonic nanoparticles and counts each one individually by dark-field micro-spectrophotometry. The AVAC Analyzer reaches femtogram-range sensitivity.
Hesperos has received an SBIR Phase II grant (R44AI197758) from NIAID to expand its Malaria-on-a-Chip platform, adding support for viable, replicating parasite strains and predictive PK/PD modeling.

UCLA researchers have shown that briefly squeezing a cell's nucleus for milliseconds can loosen tightly packed DNA and make CRISPR activation far more effective at reprogramming cell identity. After mapping which genomic regions opened, they aimed guide RNAs at those sites, raising the share of mouse skin cells converted to neurons from about 3% to 10%. Adding a priming step that activated Oct4 pushed conversion to roughly 40%.
This week in nanotech
$281.1M raised
6 funding rounds · 36 deals tracked
New products
Ti-WCMBN Nanomaterialia Featured
Nion-compatible In Situ STEM Holders for Electrical BiasingHummingbird Scientific Featured
Ionic® Purification SystemBionano Genomics, Inc.Market insights
Last 30 days: Quantum Technologies drew the most money: $3.17B.
Money raised per month
Behind the deal
Who led Xanadu Quantum Technologies Limited’s $10M Grant?
See the investors with Insights Pro →